August 30, 2014 8:21 AM ET

Biotechnology

Company Overview of MaxCyte, Inc.

Executive Profile

Douglas A. Doerfler

Co-Founder, Chief Executive Officer, President and Director, MaxCyte, Inc.
AgeTotal Calculated CompensationThis person is connected to 4 Board Members in 4 different organizations across 2 different industries.

See Board Relationships
----

Background

Mr. Douglas A. Doerfler, Doug co-founded MaxCyte, Inc. in 1999 and has been its President and Chief Executive Officer since June 1999. Mr. Doerfler served senior corporate development and operating responsibilities at PFRM, Inc., a privately owned biotechnology holding company (Novagen, Pel-Freez Clinical Systems, and Pel-Freez Biological). From May 1994 to May 1996, he served as President, Chief Executive Officer and Director of Immunicon Corporation. From 1981 to 1994, ...

Corporate Headquarters

22 Firstfield Road
Gaithersburg, Maryland 20878

United States

Phone: 301-944-1700
Fax: 301-944-1703

Board Members Memberships

Chairman of The Board
Director At Large
Vice Chairman of MdBio Division and Director
1999-Present
Co-Founder, Chief Executive Officer, President and Director

Education

MBA
The University of Chicago
BS
Robert G Merrick School of Business

Other Affiliations

Annual Compensation

There is no Annual Compensation data available.

Stocks Options

There is no Stock Options data available.

Total Compensation

There is no Total Compensation data available.
 

Stock Quotes

Market data is delayed at least 15 minutes.

Company Lookup

COMPETITOR COMPENSATION

There is no Competitor Compensation data available.

Sponsored Financial Commentaries

Sponsored Links

Report Data Issue

To contact MaxCyte, Inc., please visit . Company data is provided by Capital IQ. Please use this form to report any data issues.

Please enter your information in the following field(s):
Update Needed*

All data changes require verification from public sources. Please include the correct value or values and a source where we can verify.

Your requested update has been submitted

Our data partners will research the update request and update the information on this page if necessary. Research and follow-up could take several weeks. If you have questions, you can contact them at bwwebmaster@businessweek.com.